Sort
50,496 grants matching “lung cancer”
Enabling Ultra Low Dose PET/CT Imaging
$683,449Paul E Kinahan · University Of Washington · R01 · FY2014 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$683,382Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Rhesus HHV-8 homologue in AIDS-related malignancies
$683,330Scott W Wong · Oregon Health & Science University · R01 · FY2020 · CA
Informatics Tools for Optimized Imaging Biomarkers for Cancer Research&Discovery
$683,254Bruce R Rosen · Massachusetts General Hospital · U24 · FY2016 · CA
Characterization of Potential Harm Caused by Electronic Cigarette Flavor Chemicals and their Reaction Products
$683,205Prudence Talbot · University Of California Riverside · R01 · FY2021 · ES
Reproducible and Accurate PD-L1 Immunohistochemistry Biomarker Quantification Using Virtual Multiplex Immunofluorescence Restaining
$683,089Saad Nadeem · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
A smoke-free home intervention in federally subsidized housing
$683,085Maya Vijayaraghavan · University Of California, San Francisco · R01 · FY2023 · MD
Using MRI To Visualize Regional Therapy Response In Idiopathic Pulmonary Fibrosis
$682,999Bastiaan Driehuys · Duke University · R01 · FY2022 · HL
Genetically Informed Smoking Cessation Trial
$682,967Li-Shiun Chen · Washington University · R01 · FY2015 · DA
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
$682,890Louise C Showe · Wistar Institute · U01 · FY2016 · CA
Wearable Nanosensor Array for Real-Time Monitoring of Diesel and Gasoline Exhaust
$682,755Ashok Mulchandani · University Of California Riverside · U01 · FY2009 · ES
Winship National Clinical Trials Network Lead Academic Participating Site
$682,746Nabil F Saba · Emory University · UG1 · FY2025 · CA
Immunogenetic determinants of cancer risk
$682,727Robert M Samstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
BIOMARKERS OF EXPOSURE AND EFFECT IN A TRAFFIC EXPOSED POPULATION
$682,678Francine Laden · Brigham And Women'S Hospital · R01 · FY2008 · ES
Translating buccal nanocytology for lung cancer screening into clinical practice
$682,587Vadim Backman · Northwestern University · R01 · FY2024 · CA
Therapeutic targeting MDSC-mediated immune suppression in cancer
$682,585Yulia Nefedova · Wistar Institute · R01 · FY2023 · CA
Endothelial Toll-like Receptor 3 in the pathogenesis and therapy of Pulmonary Arterial Hypertension
$682,581Laszlo Farkas · Virginia Commonwealth University · R01 · FY2019 · HL
Real-time in vivo proton range verification in proton therapy with thallium bromide detectors
$682,577Gerard Arião Estrada · University Of California At Davis · R01 · FY2023 · EB
Precision Therapy to Target Pancreatic Ductal Adenocarcinoma
$682,524Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Optimizing Lung Cancer Screening in Cancer Survivors
$682,511Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
The clinical impact of longitudinal measures of cardiac and pulmonary vascular morphology in smokers
$682,441George R Washko · Brigham And Women'S Hospital · R01 · FY2019 · HL
PREMIERE: A PREdictive Model Index and Exchange REpository
$682,393Alex Bui · University Of California Los Angeles · R01 · FY2022 · EB
Novel metabolomic contrast probes for human lung cancer characterization
$682,367Leo L Cheng · Massachusetts General Hospital · R01 · FY2022 · CA
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
$682,315Katerina Abigail Politi · Yale University · R01 · FY2021 · CA
Joint Center for Structural Genomics
$682,200Ian A Wilson · Scripps Research Institute, The · U54 · FY2011 · GM